A coalition of 86 organizations is urging Congress to pass the Clinical Treatment Act, a bill introduced in January that would guarantee coverage of the routine care costs of clinical trial participation for Medicaid patients with a life-threatening condition.
In last week’s issue of The Cancer Letter, Jacquelyn Cobb, associate editor, wrote a story about the then-promising legislative package that was passed by the U.S. House of Representatives Jan. 22. At the time, the package was expected to pass in the Senate, provide funding for the federal government through fiscal year 2026, and prevent a government shutdown that looms Jan. 30.
